Peritoneal Carcinomatosis clinical trials at UC Irvine
2 research studies open to eligible people
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
open to eligible people ages 18 years and up
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
Orange, California
Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
open to eligible people ages 18-75
This is a phase II clinical trial assessing the safety and efficacy of sequential systemic and intraperitoneal (IP) chemotherapy in patients with primary gastric/gastroesophageal junction cancer with cytology positive peritoneal lavage and/or peritoneal carcinomatosis.
Orange, California
Our lead scientists for Peritoneal Carcinomatosis research studies include Maheswari Senthil, MD.
Last updated: